Wearable, Wireless Deep-tissue Sensing Patch for Continuous Monitoring of Recovery from Microsurgical Tissue Transfer
可穿戴式无线深层组织传感贴片,用于连续监测显微外科组织转移的恢复情况
基本信息
- 批准号:10637093
- 负责人:
- 金额:$ 32.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse eventAnimal ModelArteriesBiocompatible MaterialsBlood VesselsBlood flowBluetoothBypassCalibrationCellular PhoneCessation of lifeChronicClinicalClinical ResearchCloud ComputingComplexCreativenessCutaneousDataData DisplayDevelopmentDevice SafetyDevicesDiagnosisDrug Delivery SystemsEnsureEnvironmentEventFailureFosteringFutureGlycolatesGoalsHealthHourHuman ResourcesImmunohistochemistryImplantImplantation procedureIndividualInjectableIntelligenceLightLocationMeasurementMedical TechnologyMicrofabricationMicrosurgeryMonitorMorbidity - disease rateMusMuscleNatureNecrosisNeedlesOperative Surgical ProceduresOpticsPainPathway interactionsPatientsPerformancePersonal SatisfactionPhysical ExaminationPhysiologic MonitoringPhysiologicalPhysiologyPlayPolyvinyl AlcoholPostoperative CarePostoperative PeriodProceduresReconstructive Surgical ProceduresRecoveryRehabilitation therapyResearchRespirationRiskRoleSafetySchemeSeriesSignal TransductionSkinSurfaceSurgical FlapsSurgical ManagementSystemTechniquesTechnologyTestingThrombosisTimeTissuesToxic effectUnited States National Institutes of HealthVascular blood supplyVeinsVisionWorkbasebiomaterial compatibilityblood gas analyzerdesigndiagnostic technologieselectronic sensorfabricationhemodynamicshistological studiesimplantationimprovedinnovationinstrumentationlithographymultimodalitynext generationnovelpersonalized medicineporcine modelpreventreal time monitoringremote health caresensor technologyskillssuccesssurgery outcometechnology platformtissue oxygenationwaveguidewearable devicewearable sensor technologywirelesswireless communicationwound carewound healing
项目摘要
Technologies that can closely monitor surgical recovery and wound healing for timely, proactive
treatments represent an essential keystone to developing next-generation personalized medicine that can further
reduce patient pain, prevent morbidity and death, and improve individual wellbeing. Microsurgical tissue transfer
entails surgical elevation of a portion of tissue (or flap) based upon its defined vascular supply in the form of a
single artery and vein. While this reconstructive strategy is well-accepted, failures do occur and almost always
result from early microvascular thrombosis. This flap-threatening event occurs in 6-14% of cases, and if
untreated flap necrosis and reconstructive failure are inevitable. The most common flap monitoring strategies is
serial physical examination and external doppler examination. However, these strartegies are limited by its
inherently subjective nature and the requirement for skilled bedside personnel to check the flap frequently. And
the intermittent assessment is subject to delay in the diagnosis of malperfusion, since clear signs of malperfusion
may take several hours to become obvious. Recent developments in wearable electronic sensors with built-in
systems on chip enable opportunities for real-time monitoring of physiological conditions of targeted tissues.
However, wearable biosensors that feature skin-interface pose a challenge: to sense physiological
parameters such as oxygenation of tissue microenvironments at depth. In the case of flap monitoring,
existing devices such as ViOptix are only able to monitor flaps which bear a cutaneous skin. This deficiency
means that muscle flaps must be monitored with indirect sensing technology through neighboring skin, which is
predisposed to delay recognition of muscle malperfusion.
This absence of direct, real-time monitoring technology for muscle-only flaps gives rise to the
fundamental and overarching unmet clinical need: to advance technological platforms for deep-tissue
monitoring. We propose a soft wearable intelligent patch (SWIP) that incorporates microneedle waveguides
to enable deep-tissue sensing of oxygenation without implantation procedures for continuous monitoring of
recovery after microsurgical tissue transfer. We aim for the proposed device to enable physiological
measurements from 4 different locations of skin to yield both local (tissue oxygenation, pulsation intensity, and
blood flow rate) and global (pulsation rate and respiration rate) physiological information continuously and
simultaneously. The sensing interface will rely on biocompatible, optical waveguides in the form of microneedles
to enable light-matter interaction at deep tissue (~ 2 cm below the skin surface). The device will be equipped
with a control module that provides a series of signal pre-processing and a Bluetooth Low Energy (BLE) interface
to advertise the data for further processing by a cloud-based computing device. We envision that the proposed
SWIP will advance diagnostic technology for reconstructive surgery and beyond, and offer real-time monitoring
to facilitate precise customization and personalization in surgical recovery and rehabilitation.
可密切监控手术恢复和伤口愈合的技术,以便及时、主动地
治疗是开发下一代个性化药物的关键,这种药物可以进一步
减轻患者痛苦,防止发病和死亡,改善个人福祉。显微外科组织移植
需要手术抬高一部分组织(或皮瓣),根据其定义的血管供应的形式
单一的动脉和静脉。虽然这种重建策略被广泛接受,但失败确实会发生,而且几乎总是
是早期微血管血栓形成的结果。这种威胁襟翼的事件发生在6%-14%的病例中,如果
未经处理的皮瓣坏死和重建失败是不可避免的。最常见的襟翼监测策略是
连续体检和体外多普勒检查。然而,这些战略受到其自身的限制
固有的主观性和对熟练床边人员频繁检查瓣的要求。和
间歇性评估可能会延迟诊断灌注不良,因为有明显的灌注不良迹象。
可能需要几个小时才能变得明显。内置可穿戴电子传感器的最新发展
片上系统使实时监测目标组织的生理状况成为可能。
然而,以皮肤界面为特征的可穿戴生物传感器构成了一个挑战:感知生理
深度组织微环境的氧合等参数。在襟翼监控的情况下,
现有的设备,如ViOptix,只能监测带有皮肤的皮瓣。这一缺陷
这意味着肌瓣必须通过邻近的皮肤通过间接传感技术进行监测,这是
倾向于延迟对肌肉灌注不良的识别。
由于缺乏对纯肌肉皮瓣的直接、实时监测技术,导致
尚未满足的基本和总体临床需求:推进深层组织技术平台
监控。我们提出了一种结合了微细波导的软可穿戴智能贴片(SWIP
无需植入程序即可实现深层组织氧合传感,以持续监测
显微外科组织移植术后恢复正常。我们的目标是使拟议的设备能够实现生理学
从4个不同的皮肤位置进行测量,得出局部(组织氧合、脉搏强度和
血流率)和全局(脉动率和呼吸率)生理信息连续和
同时。传感接口将依赖于生物兼容的微针形式的光波导
以在深层组织(皮肤表面下约2厘米)实现光与物质的相互作用。该装置将配备
具有提供一系列信号预处理的控制模块和蓝牙低能量(BLE)接口
以广告数据以供基于云的计算设备进一步处理。我们设想,拟议的
Swip将为重建手术和其他领域推进诊断技术,并提供实时监控
以促进外科康复和康复中的精确定制和个性化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wubin Bai其他文献
Wubin Bai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 32.82万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 32.82万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 32.82万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 32.82万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 32.82万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 32.82万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 32.82万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 32.82万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 32.82万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 32.82万 - 项目类别: